EP News Bureau

GlobalData attributes surge in CNS oligonucleotide licensing to increased adoption of ASOs and siRNAs, alongside advancements in…

The acquisition expands Rubicon’s manufacturing footprint and capabilities in high-potency formulations, supporting its US market…

Glenmark Pharmaceuticals introduces tislelizumab following CDSCO approval, expanding its oncology portfolio with its first…

Ameetkumar H Desai, Bhaskar V Iyer, Shirish G Belapure, and Monica H Kanuga join CORONA Remedies’ Board as Independent Directors…

Madhu of SG Pharma Solutions highlights why extractables and leachables (E&L) studies frequently fail regulatory review and…

The event will highlight collaborative approaches to risk management, compliance, and technology integration for safer…

Efsitora met primary endpoints across three Phase 3 trials, showing comparable glucose control to daily basal insulin therapies

In this final instalment, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech, transitions from analysis to action. Drawing on…

In this second part, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech continues the discussion on FDA expectations, with…

GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…